QSI Stock Price Today (October 2026) — Quantum-Si incorporated Analysis & Key Metrics 2026-10-23
Quantum-Si incorporated (QSI) is trading at $1.40, up 21.74% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $2.28 (62.9% upside).
- Volatility is high (158.33% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: declining revenue trends (-41.80% YoY) alongside competitive pressures in the Medical Devices space.
QSI Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Quantum-Si incorporated - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $197.95M
P/E Ratio
Forward P/E: N/A
Revenue Growth
Year over Year
Analyst Target
+62.9% upside potential
Key Investor Questions About QSI
What investors need to know before buying
Based on current market data, QSI presents a neutral technical setup with challenging fundamentals.
- Technicals say: Neutral (RSI 59.51)
- Fundamentals say: Challenging (declining revenue trends)
QSI's growth trajectory depends on its ability to expand within the Medical Devices sector while managing margin pressures.
- Future growth will depend on performance in core Medical Devices operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for QSI investors include debt exposure and competitive dynamics in the Medical Devices industry.
- $3.25M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Medical Devices.
52-Week Trading Range
Over the past year, QSI stock traded between $0.69 and $2.44 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 158.33% annualized volatility and β=3.60, the stock exhibits high sensitivity to market moves—making QSI suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
Lower institutional support combined with high short selling points to negative sentiment.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Quantum-Si Regains Compliance With Nasdaq's Minimum Bid Price Requirement
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
BC-Most Active Stocks
Quantum-Si Detects 19 Amino Acids in Proteus Program
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Latest TickZen Insights
All insights →No TickZen article on QSI yet. Our newest analysis:
Explore More Analysis for QSI
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Nov 5, 2026 (after the close, usually)
Frequently Asked Questions
Common investor questions about Quantum-Si incorporated
Quantum-Si incorporated (QSI) is currently trading at $1.40. The RSI (14-day) is at 59.5, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $2.28 implies 62.9% upside from current levels. Volatility is high at 158.3% annualized, meaning significant price swings are common. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Quantum-Si incorporated (QSI): The trailing P/E ratio is not available (the company may not be profitable). Price-to-Book is 1.70. Price-to-Sales is 190.93. Valuation should be compared to Medical Devices industry peers for context, as different sectors trade at different multiples.
Based on 3 analysts covering QSI, the consensus price target is $2.28. This represents a 62.9% upside from the current price of $1.40. The range spans from a low target of $1.00 to a high target of $3.95, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Quantum-Si incorporated (QSI) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Quantum-Si incorporated (QSI) investors include: 1. High volatility (158.3% annualized)—the stock can experience significant daily price swings. 2. The company is not currently profitable on a trailing basis, which creates earnings uncertainty. 3. Declining revenue (-41.8% YoY), indicating potential business headwinds. 4. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 5. Medical Devices sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Quantum-Si incorporated's (QSI) current debt and financial health profile: Total debt stands at $3.25M. The debt-to-equity ratio is 0.02x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 9.97, indicating strong short-term liquidity. The quick ratio is 9.36. The company holds $111.74M in cash and equivalents. Free cash flow is negative at -$93.69M, which could limit the company's ability to manage debt obligations.